|
1
|
The 2007 WHO classification of tumours of the central nervous system.
|
Acta Neuropathol
|
2007
|
49.11
|
|
2
|
Genetic pathways to primary and secondary glioblastoma.
|
Am J Pathol
|
2007
|
9.27
|
|
3
|
Genetic pathways to glioblastoma: a population-based study.
|
Cancer Res
|
2004
|
8.87
|
|
4
|
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas.
|
Am J Pathol
|
2009
|
6.43
|
|
5
|
Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
|
J Neuropathol Exp Neurol
|
2005
|
6.16
|
|
6
|
Epidemiology and etiology of gliomas.
|
Acta Neuropathol
|
2005
|
6.14
|
|
7
|
The definition of primary and secondary glioblastoma.
|
Clin Cancer Res
|
2012
|
3.84
|
|
8
|
Integrity of the conduct of the IARC monographs program.
|
Int J Occup Environ Health
|
2003
|
3.55
|
|
9
|
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading.
|
Brain Pathol
|
2014
|
3.21
|
|
10
|
IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.
|
Clin Cancer Res
|
2009
|
2.95
|
|
11
|
Genetic alterations and signaling pathways in the evolution of gliomas.
|
Cancer Sci
|
2009
|
2.75
|
|
12
|
Age as a predictive factor in glioblastomas: population-based study.
|
Neuroepidemiology
|
2009
|
2.44
|
|
13
|
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.
|
Acta Neuropathol
|
2004
|
2.15
|
|
14
|
Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
|
Cancer Res
|
2003
|
2.08
|
|
15
|
The science and practice of carcinogen identification and evaluation.
|
Environ Health Perspect
|
2004
|
1.89
|
|
16
|
A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma.
|
J Neurosurg
|
2003
|
1.60
|
|
17
|
Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas.
|
Brain Pathol
|
2004
|
1.59
|
|
18
|
Molecular classification of low-grade diffuse gliomas.
|
Am J Pathol
|
2010
|
1.51
|
|
19
|
TERT promoter mutations in primary and secondary glioblastomas.
|
Acta Neuropathol
|
2013
|
1.51
|
|
20
|
Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.
|
Acta Neuropathol
|
2001
|
1.38
|
|
21
|
PTEN methylation and expression in glioblastomas.
|
Acta Neuropathol
|
2003
|
1.31
|
|
22
|
Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) mice.
|
Am J Pathol
|
2003
|
1.28
|
|
23
|
Molecular pathogenesis of astrocytic tumours.
|
J Neurooncol
|
2004
|
1.24
|
|
24
|
Genetic profile of astrocytic and oligodendroglial gliomas.
|
Brain Tumor Pathol
|
2011
|
1.18
|
|
25
|
AXIN1 mutations but not deletions in cerebellar medulloblastomas.
|
Oncogene
|
2003
|
1.13
|
|
26
|
Stratification of medulloblastoma on the basis of histopathological grading.
|
Acta Neuropathol
|
2006
|
1.01
|
|
27
|
Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
|
Clin Cancer Res
|
2002
|
0.99
|
|
28
|
Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndrome.
|
Acta Neuropathol
|
2009
|
0.97
|
|
29
|
Genetic profiling of CNS tumors extends histological classification.
|
Acta Neuropathol
|
2010
|
0.94
|
|
30
|
Intratumoral patterns of genomic imbalance in glioblastomas.
|
Brain Pathol
|
2010
|
0.94
|
|
31
|
Gene expression profiling and subgroup identification of oligodendrogliomas.
|
Oncogene
|
2004
|
0.89
|
|
32
|
Methylation of the p73 gene in gliomas.
|
Acta Neuropathol
|
2002
|
0.87
|
|
33
|
Brain tumors in S100beta-v-erbB transgenic rats.
|
J Neuropathol Exp Neurol
|
2006
|
0.82
|
|
34
|
Role of Biomarkers in the Clinical Management of Glioblastomas: What are the Barriers and How Can We Overcome Them?
|
Front Neurol
|
2013
|
0.82
|
|
35
|
Definition of primary and secondary glioblastoma--response.
|
Clin Cancer Res
|
2014
|
0.82
|
|
36
|
Cerebellar liponeurocytoma with an unusually aggressive clinical course: case report.
|
Neurosurgery
|
2003
|
0.81
|
|
37
|
Endogenous deoxyribonucleic Acid (DNA) damage in human tissues: a comparison of ethenobases with aldehydic DNA lesions.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
0.80
|
|
38
|
Genetic and expression profiles of cerebellar liponeurocytomas.
|
Brain Pathol
|
2004
|
0.80
|
|
39
|
Alterations of the RRAS and ERCC1 genes at 19q13 in gemistocytic astrocytomas.
|
J Neuropathol Exp Neurol
|
2014
|
0.75
|
|
40
|
Transparency at the International Agency for Research on Cancer (IARC).
|
Lancet
|
2003
|
0.75
|
|
41
|
Reply to Dr. Sass.
|
Int J Occup Environ Health
|
2003
|
0.75
|
|
42
|
Reply to Marc Scherer.
|
Brain Pathol
|
2013
|
0.75
|
|
43
|
Nutrition and cancer: a complex relationship.
|
IARC Sci Publ
|
2002
|
0.75
|